PDF(1430 KB)
Clinical efficacy and safety of repetitive transcranial magnetic stimulation in vascular dementia:A meta-analysis
Mei YANG, Jing CAI, Xiaoshan WANG, Hongyan WU
Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2025, Vol. 8 ›› Issue (6) : 383-390.
PDF(1430 KB)
Abbreviation (ISO4): Chinese Journal of Alzheimer's Disease and Related Disorders
Editor in chief: Jun WANG
PDF(1430 KB)
Clinical efficacy and safety of repetitive transcranial magnetic stimulation in vascular dementia:A meta-analysis
Objective: To systematically evaluate the efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) in the treatment of vascular dementia(VaD). Methods: Randomized controlled trials (RCTs) investigating rTMS for VaD were retrieved from Chinese and English databases from inception to May 2025. After screening based on predefined inclusion and exclusion criteria, a meta-analysis was performed using RevMan 5.4 software. Results: A total of 15 eligible RCTs involving 1,296 patients were included. The meta-analysis demonstrated that, compared with the control group, rTMS significantly improved clinical response rate [RR=1.26,95%CI(1.18,1.35),P<0.00001], Montreal Cognitive Assessment (MoCA) score [MD=1.84,95%CI(1.27,2.41),P<0.00001], Mini-Mental State Examination (MMSE) score [MD=3.81,95%CI(3.43,4.19),P<0.00001], Hasegawa Dementia Scale (HDS) score [MD=3.48,95%CI(2.94,4.03),P<0.00001], National Institutes of Health Stroke Scale (NIHSS) score [MD=-1.23,95%CI(-1.47,-0.99),P<0.00001], and Activities of Daily Living (ADL) score [MD=6.72,95%CI(5.70,7.74),P<0.00001]. All differences were statistically significant. Adverse effects of rTMS were mild, with good patient tolerance and high safety. Conclusion: rTMS demonstrates significant efficacy in improving cognitive function, activities of daily living, andneurological deficits in VaD patients, while maintaining high treatment safety.
Repetitive transcranial magnetic stimulation / Vascular dementia / Randomized controlled trial / Meta-analysis
| [1] |
The notion of what qualifies as vascular dementia has varied greatly since the first mention of dementia after apoplexy in ancient literature. Current insight points towards a multifactorial cause of cognitive decline at old age, in which vascular components like atherosclerosis, arterio(lo)sclerosis, (micro)infarcts, and amyloid angiopathy play an important role alongside other markers of neurodegeneration. Cerebrovascular disease will be present in most individuals with dementia, but—just like other causes—rarely a cause on its own. The consequent limitations of nosology may be alleviated by addition of a vascular component to the recently introduced amyloid/tau/neurodegeneration etiological classification system for dementia. Meanwhile, risk of dementia is increased about 2-fold after stroke, and the prevention of (recurrent) stroke remains a cornerstone in the prevention of vascular dementia. Similarly, control of cardiovascular risk factors from middle age onwards is likely to have contributed to the reported decline in the age-specific incidence of dementia over the past decades. In conjunction with experimental studies, large-scale observational evidence from imaging, genomics, metabolomics, and alike will continue to improve our understanding of the underlying pathophysiological processes. To prevent ecological fallacies, such etiological studies in patients with dementia are best served by inclusion of subjects regardless of the presumed (single) cause of their disease.
|
| [2] |
|
| [3] |
中国卒中学会血管性认知障碍分会. 中国血管性认知障碍诊治指南(2024版)[J]. 中华医学杂志, 2024, 104(31):2881-2894.
|
| [4] |
张伊菲, 白洁如, 蔡冰茹, 等. 重复经颅磁刺激治疗认知障碍机制研究进展[J]. 辽宁中医药大学学报, 2025, 27(10):63-68.
|
| [5] |
This study aimed to evaluate the effects of repetitive transcranial magnetic stimulation (rTMS) on learning and memory in a rat model of vascular dementia (VaD) and to analyze the associated mechanisms. Bilateral carotid artery occlusion (2-VO) was used to establish a rat model of VaD. High-frequency (5Hz) rTMS was performed on rats for four weeks. Spatial learning and memory abilities were evaluated using the Morris water maze (MWM), and synaptic plasticity in the hippocampus was assessed via long-term potentiation (LTP). Hippocampal expression of vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor (BDNF) and three subunits of the N-methyl-D-aspartic acid receptor (NMDAR), NR1, NR2A and NR2B, was analyzed by Western blotting. Compared with the VaD group, escape latency was decreased (P<0.05) and the time spent in the target quadrant and the percentage of swimming distance within that quadrant were increased (P<0.05) in the rTMS group. LTP at hippocampal CA3-CA1 synapses was enhanced by rTMS (P<0.05). VEGF expression was up-regulated following 2-VO and was further increased by rTMS (P<0.05). BDNF, NR1 and NR2B expression was decreased in the VaD group and increased by rTMS (P<0.05). There were no significant differences in NR2A expression among the three groups. These results suggest that rTMS improved learning and memory in the VaD model rats via the up-regulation of VEGF, BDNF and NMDARs. In addition, NR2B may be more important than NR2A for LTP induction in the hippocampus during rTMS treatment of VaD.Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.
|
| [6] |
陈卓, 李颖, 郝赤子, 等. 重复经颅磁刺激治疗非痴呆性血管性认知障碍的Meta分析[J]. 武汉大学学报(医学版), 2018, 39(2):333-339.
|
| [7] |
周文, 张文超, 黄开秀, 等. 重复经颅磁刺激对血管性认知障碍疗效的Meta分析[J]. 中国全科医学, 2020, 23(31):3976-3982.
背景 血管性认知障碍(VCI)不仅影响患者的生活质量,还给患者的全面功能康复带来较大困难。重复经颅磁刺激(rTMS)在神经系统和精神性疾病治疗方面的应用受到越来越多的关注,研究rTMS对VCI的疗效,对寻找非药物手段治疗VCI具有重要意义。目的 系统评价rTMS对我国VCI患者的疗效。方法 2019年10月—2020年1月,使用Cochrane协作网提供的系统评价方法,系统全面检索PubMed、Embase、EBSCO、Web of Science、Cochrane Library和中国知网数据库。同时筛查纳入文献的参考文献,结合手工检索相关期刊及灰色文献,检索时间截至2019-12-30,纳入关于rTMS治疗VCI的临床随机对照研究。由两名评价者采用Cochrane偏倚风险评估工具进行文献质量评价,采用RevMan 5.3软件进行Meta分析。结果 共纳入12篇临床随机对照文章,包括837例患者。Cochrane偏倚风险评估结果显示,12篇文献中,5篇报道了具体的随机分组方法,2篇进行了分配隐藏,2篇报道了避免测量偏倚的方法。Meta分析结果提示rTMS能够提高脑卒中患者的蒙特利尔认知评估量表(MoCA)、简易智力状态检查量表(MMSE)及Loewenstein认知功能评定表(LOTCA)评分。进行敏感性分析后,MoCA评分和MMSE评分结果采用固定效应模型,其总体效应值分别为:WMD=2.52,95%CI(2.04,3.00),P<0.05;WMD=1.55,95%CI(1.04,2.07),P<0.05。LOTCA评分因文献数量限制而采用定性分析,结果显示rTMS对其改善具有积极作用(P<0.05)。结论 rTMS对VCI患者的认知功能具有一定改善作用。但目前仍存在临床试验不够规范和研究样本量较小等问题,未来还需要更多高质量、大样本、多中心的随机对照研究来观察rTMS对VCI的疗效。
|
| [8] |
李翠翠, 朱应超, 李静, 等. HF-rTMS联合盐酸美金刚与尼莫地平治疗血管性痴呆的疗效及对内皮细胞功能的影响[J]. 中国实用神经疾病杂志, 2025, 28(1):33-36.
|
| [9] |
周甜甜, 苏文杰, 连松勇, 等. 重复经颅磁刺激对脑卒中后血管性痴呆患者认知功能的疗效研究[J]. 中医康复, 2025, 2(4):66-71.
|
| [10] |
刘小翡, 姜洪新, 隋汝波, 等. 重复经颅磁刺激改善血管性痴呆认知功能磁共振成像效果分析[J]. 锦州医科大学学报, 2024, 45(4):36-41.
|
| [11] |
吴秀玲, 叶鑫武, 林永坚, 等. 重复经颅磁刺激联合胞磷胆碱钠片治疗脑梗死后血管性痴呆的疗效研究[J]. 心电与循环, 2024, 43(2):162-165,176.
|
| [12] |
杨明健. 高频重复经颅磁刺激联合尼莫地平治疗血管性痴呆的效果[J]. 中国当代医药, 2023, 30(11):11-15.
|
| [13] |
袁玉杰, 张晓君. 经颅磁刺激联合丁苯酞对脑梗死后血管性痴呆患者血清NGF、NSE、BDNF的影响[J]. 慢性病学杂志, 2023, 24(9):1349-1351,1355.
|
| [14] |
郝建伟, 李杰, 李勤勤, 等. 奥拉西坦联合重复经颅磁刺激治疗脑梗死后血管性痴呆患者效果观察[J]. 内科, 2022, 17(1):21-24.
|
| [15] |
安红英. rTMS联合阿司匹林、阿托伐他汀钙及多奈哌齐治疗老年血管性痴呆患者的疗效观察[J]. 首都食品与医药, 2021, 28(16):80-81.
|
| [16] |
汪恒胜, 张新英. 重复经颅磁刺激联合常规抗痴呆治疗在老年血管性痴呆患者中的应用效果[J]. 实用临床医药杂志, 2020, 24(17):31-35.
|
| [17] |
李航, 曹秀丽, 钟小明, 等. 重复经颅磁刺激治疗血管性痴呆对患者血清NSE水平及认知功能的影响[J]. 检验医学与临床, 2020, 17(5):647-649,710.
|
| [18] |
任雅芳, 付胜奇, 禹萌, 等. 丁苯酞联合rTMS对血管性痴呆患者临床疗效及血清Ang-ⅠMMP-9LPO水平的影响[J]. 临床心身疾病杂志, 2018, 24(6):2725-2762.
|
| [19] |
王金彩, 吉四辈, 宋志秀, 等. 丁苯酞软胶囊联合重复经颅磁刺激对血管性痴呆患者血清Ang-Ⅰ、MMP-9水平变化的影响[J]. 中国合理用药探索, 2018, 15(6):70-72.
|
| [20] |
王学红. 奥拉西坦联合重复经颅磁刺激治疗血管性痴呆的疗效观察[J]. 中国实用神经疾病杂志, 2016, 19(7):57-58.
|
| [21] |
陆强彬, 朱祖福, 张慧萍, 等. 重复经颅磁刺激治疗轻中度血管性痴呆的对照研究[J]. 实用医学杂志, 2013, 29(17):2846-2847.
|
| [22] |
汪艳, 张兆蓬, 王学员, 等. 电针配合重复经颅磁刺激治疗血管性痴呆49例[J]. 陕西中医, 2012, 33(1):82-84.
|
| [23] |
余倩, 于涛. 重复性经颅磁刺激治疗血管性痴呆机制的研究进展[J]. 神经损伤与功能重建, 2024, 19(10):597-599.
|
| [24] |
赵嘉培, 陈善佳, 黄吉莉, 等. 高频重复经颅磁刺激对血管性痴呆大鼠学习记忆能力的影响及机制[J]. 解剖学研究, 2024, 46(5):483-488.
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
于哲一, 张伟明. 重复经颅磁刺激对脑卒中患者认知功能障碍的影响[J]. 康复学报, 2019, 29(5):20-26.
|
| [31] |
|
/
| 〈 |
|
〉 |